The Board of Directors of Cannara Biotech Inc. has authorized a buyback plan on November 11, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 CAD | -3.70% | +2.63% | -6.02% |
1st Jan change | Capi. | |
---|---|---|
-6.02% | 53.29M | |
-.--% | 339M | |
+31.96% | 279M | |
+37.45% | 266M | |
+47.09% | 190M | |
+156.53% | 145M | |
-38.39% | 133M | |
+15.38% | 100M | |
-42.86% | 96.7M | |
+10.34% | 57.41M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Cannara Biotech Inc. authorizes a Buyback Plan.